Form 4: Marpai Director Buys Shares & Warrants in Private Placement

Marpai Director Robert M. Pons acquired 50,000 shares of common stock and warrants for 100,000 shares in a private placement offering.

Summary

• Robert M. Pons, a Director of Marpai, Inc. (MRAI), purchased securities in a private placement offering on November 7, 2025.
• The purchase included 50,000 shares of Class A Common Stock and common warrants to purchase up to 100,000 shares of common stock.
• The purchase price for each share of common stock and accompanying common warrant was $1.00.
• The common warrants have an exercise price of $1.00 per share and are exercisable immediately following the closing of the private placement.
• The warrants will be exercisable for three years following the date of issuance, expiring on November 6, 2028.
• Following this transaction, Robert M. Pons beneficially owns 359,200 shares of Class A Common Stock directly.
• Additionally, Robert M. Pons beneficially owns 100,000 common warrants directly.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to a significant insider purchase by a director in a private placement, indicating strong confidence in the company's future.

Positives

• A Director, Robert M. Pons, increased his direct beneficial ownership in Marpai, Inc. by purchasing 50,000 shares of common stock and warrants for an additional 100,000 shares, signaling strong insider confidence.
• The private placement offering indicates the company successfully raised capital from an insider at a price of $1.00 per unit (share plus warrant).

Future Outlook

The filing does not contain explicit forward-looking statements or guidance, but the insider purchase can be interpreted as a positive outlook from management.

Management Comments

• On November 7, 2025, Marpai Inc. (the "Company") entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 50,000 shares of common stock of the Company and common warrants to purchase up to 100,000 shares of common stock of the Company.

Industry Context

Insider buying, particularly by a director, is often viewed by the market as a strong signal of confidence in the company's future performance and valuation. This transaction suggests that a key insider believes Marpai, Inc. is undervalued or has significant growth potential.

Comparison to Industry Standards

• Insider purchases, especially in private placements, are generally seen as a positive indicator, aligning management's interests with shareholders. While specific comparable companies or projects are not detailed in this filing, such transactions are common across industries when insiders perceive value.

Related Party Transactions

• The reporting person, Robert M. Pons, is a Director of Marpai, Inc. and participated in a private placement offering with the company, making this a related party transaction.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive signal, potentially increasing investor confidence and demand for the stock.
• The company benefits from the capital raised through the private placement.

Next Steps

• The common warrants held by Robert M. Pons can be exercised immediately following the closing of the private placement offering and will be exercisable for three years until November 6, 2028.

Key Dates

Recommendation

The director's significant purchase of shares and warrants in a private placement suggests strong insider confidence in Marpai's future prospects. This type of insider buying often precedes positive company developments and can be a compelling signal for investors to consider a 'buy' position, aligning with the director's belief in the company's value.

Keywords

Marpai, MRAI, insider transaction, Form 4, beneficial ownership, private placement, common stock, warrants, director purchase